Effectiveness of the 2023-2024 monovalent XBB.1.5 vaccine against SARS-CoV-2 infection in people aged over 65 years in South Korea: a population-based cohort study
These findings support continued COVID-19 vaccination efforts, particularly in older adults. Regular vaccination remains essential to maintaining immunity and mitigating transmission, guiding future strategies against emerging SARS-CoV-2 variants.
Authors
- Kyong Ran Peck (ORCID: https://orcid.org/0000-0002-7464-9780)
- Ah-Ra Kim (ORCID: https://orcid.org/0000-0003-4762-9853)
- Byung Chul Chun (ORCID: https://orcid.org/0000-0001-6576-8916)
- Suyoung Jo (ORCID: https://orcid.org/0000-0001-7790-0160)
- Hye‐Sung Won (ORCID: https://orcid.org/0000-0003-0611-2401)
- Gi‐eun Rhie (ORCID: https://orcid.org/0000-0002-4212-5501)
- June-Woo Lee (ORCID: https://orcid.org/0000-0002-2923-5597)
- Seunghyun Lee (ORCID: https://orcid.org/0000-0003-1858-0640)
- Dong‐Hyun Kim (ORCID: https://orcid.org/0000-0003-4783-7900)
- Hanna Kim (ORCID: https://orcid.org/0000-0001-5334-2838)
- Hye-Sook Jeong (ORCID: https://orcid.org/0000-0003-2027-006X)
Institutions
- Seoul National University (KR)
- Hallym University (KR)
- Korea University (KR)
- Samsung Medical Center (KR)
- Korea National Institute of Health (KR)
- Pusan National University (KR)
- Chung-Ang University (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.ijid.2025.108238
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Korea Disease Control and Prevention Agency
- National Institutes of Health